PR-307

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NamePR-307

Drug Alias NamePR-307

ClassificationSmall molecules > Prodrug > Directed prodrug therapy

Mechanisms of ActionBioreducible cytotoxin

TargetsUpdating

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryNew Zealand

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesProacta Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesProacta Inc

Active IndicationsN/A

Inactive IndicationsSolid tumours

ATC CodeN/A